Cogent Biosciences announced positive top-line results from its SUMMIT clinical trial of bezuclastinib for non-advanced systemic mastocytosis (NonAdvSM). The...

A recent study published in •Med• revealed that Plinabulin, in combination with radiation and PD-1 inhibitors, shows promise in...

Ashvattha Therapeutics announced interim Phase 2 trial results for its subcutaneous migaldendranib (MGB), a potential treatment for diabetic macular...

Chemomab Therapeutics announced positive Phase 2 SPRING trial data for nebokitug (CM-101) in patients with primary sclerosing cholangitis (PSC)...

Corbus Pharmaceuticals has initiated the multiple ascending dose (MAD) portion of its Phase 1 trial for CRB-913, an obesity...

Assembly Biosciences has dosed the first participant in a Phase 1b study of ABI-1179, an oral, long-acting herpes simplex...

Stereotaxis announced the publication of initial clinical results for its MAGiC robotic magnetic navigation ablation catheter in the Journal...

CytoDyn announced encouraging clinical findings from a compassionate use study of leronlimab in patients with advanced metastatic colorectal cancer...

Cognition Therapeutics announced that its Phase 2 START Study for Alzheimer’s disease has surpassed 50% enrollment. The study, conducted...

BioXcel Therapeutics’ independent Data Safety Monitoring Board (DSMB) recommended the continuation of the SERENITY At-Home Phase 3 safety trial...